Development of a Digital Acceptance and Commitment Therapy Intervention for Suicide Prevention in Adults Through Co-design
23. juli 2026 opdateret af: The Hong Kong Polytechnic University
Suicide is a major public health concern and there is a need for accessible and scalable interventions to support individuals experiencing suicidal thoughts.
The aim of this study is to develop a digital Acceptance and Commitment Therapy (ACT) intervention for suicide prevention in Chinese adults through co-design.
The study will involve literature review, interviews, and co-design activities to identify user needs, preferences, and contextual factors, and to develop the intervention.
Following intervention development, a pilot study will be conducted to evaluate the feasibility, usability, acceptability, and user engagement of the intervention.
Findings from this study will inform further refinement of the intervention and future evaluation studies.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
80
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Tao Zhang
- Telefonnummer: +85294233827
- E-mail: tao-t.zhang@connect.polyu.hk
Studiesteder
-
-
-
Hong Kong, Kina
- The Hong Kong Polytechnic University
-
Kontakt:
- Bryant Hui
- Telefonnummer: +85227667744
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria Lived experience participants
- Aged 18 years or older;
- Have experienced suicidal thoughts and/or behaviors;
- Able to read and communicate in Chinese; Professionals
- Aged 18 years or older;
- Professionals with experience relevant to suicide prevention, Acceptance and Commitment Therapy (ACT), digital mental health, or related fields;
Exclusion Criteria
- Unable to provide informed consent or participate in study activities;
- Currently experiencing acute suicide risk requiring immediate intervention;
- Severe cognitive impairment or active psychotic symptoms that would prevent participation.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Digital ACT Intervention
The Digital ACT Intervention will be co-designed with stakeholders and informed by co-design activities.
The intervention aims to support adults experiencing suicidal thoughts through a digital platform.
|
A co-designed digital Acceptance and Commitment Therapy (ACT) intervention for suicide prevention
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Intervention completion rate
Tidsramme: End of the intervention (approximately 2 weeks)
|
The intervention completion rate will be assessed as the percentage of participants who complete the digital intervention, based on intervention usage records.
|
End of the intervention (approximately 2 weeks)
|
|
Retention rate
Tidsramme: End of the 1-month follow-up
|
The participant retention rate will be assessed as the percentage of participants who complete the post-intervention assessment and the follow-up assessment.
|
End of the 1-month follow-up
|
|
Acceptability outcome
Tidsramme: End of the intervention (approximately 2 weeks)
|
Acceptability of the intervention will be assessed using participant-reported ratings and feedback regarding satisfaction and overall experience with the intervention.
|
End of the intervention (approximately 2 weeks)
|
|
Usability outcome
Tidsramme: End of the intervention (approximately 2 weeks)
|
Usability will be assessed using the System Usability Scale (SUS), a 10-item self-report questionnaire.
Total scores range from 0 to 100, with higher scores indicating better usability of the intervention.
|
End of the intervention (approximately 2 weeks)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Suicide ideation
Tidsramme: Baseline, end of the 2-week intervention, and 1-month follow-up
|
Suicidal ideation will be assessed using the Beck Scale for Suicide Ideation (BSSI).
Each item is rated on a 3-point scale ranging from 0 to 2, with higher scores indicating greater suicidal ideation.
|
Baseline, end of the 2-week intervention, and 1-month follow-up
|
|
Psychological flexibility and inflexibility
Tidsramme: Baseline, end of the 2-week intervention, and 1-month follow-up
|
Psychological flexibility and inflexibility will be assessed using the Multidimensional Psychological Flexibility Inventory-24 (MPFI-24).
Each item is rated on a 6-point scale ranging from 1 to 6. Higher scores on the flexibility and inflexibility subscales indicate greater psychological flexibility and psychological inflexibility, respectively.
|
Baseline, end of the 2-week intervention, and 1-month follow-up
|
|
Psychological Distress
Tidsramme: Baseline, end of the 2-week intervention, and 1-month follow-up
|
Psychological distress will be assessed using the Depression Anxiety Stress Scales (DASS).
Each item is rated on a 4-point scale ranging from 0 to 3, with higher scores indicating greater psychological distress.
|
Baseline, end of the 2-week intervention, and 1-month follow-up
|
|
Mental well-being
Tidsramme: Baseline, end of the 2-week intervention, and 1-month follow-up
|
Mental well-being will be assessed using the Mental Health Continuum-Short Form (MHC-SF).
Each item is rated on a 6-point scale ranging from 0 to 5, with higher scores indicating greater mental well-being.
|
Baseline, end of the 2-week intervention, and 1-month follow-up
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Qualitative Feedback and Design Recommendations
Tidsramme: Through study completion, an average of 6 months
|
Qualitative feedback related to user needs, preferences, barriers, facilitators, cultural considerations, and recommendations for intervention refinement will be identified from co-design activities and feedback sessions.
|
Through study completion, an average of 6 months
|
|
Cultural Relevance
Tidsramme: Through study completion, an average of 6 months
|
Cultural relevance of the intervention will be assessed through participant feedback regarding the appropriateness, relevance, and cultural fit of the intervention content and delivery.
|
Through study completion, an average of 6 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Tao Zhang, The Hong Kong Polytechnic University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
15. juli 2026
Primær færdiggørelse (Anslået)
31. oktober 2026
Studieafslutning (Anslået)
30. december 2026
Datoer for studieregistrering
Først indsendt
9. juli 2026
Først indsendt, der opfyldte QC-kriterier
23. juli 2026
Først opslået (Faktiske)
29. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
29. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
23. juli 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- HSEARS20260122008-1
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .